Sodium Dithionite in Sickle Solubility Assay
The sodium dithionite in the sickle solubility test reduces hemoglobins, making sickling hemoglobins (HbS) insoluble while normal hemoglobins remain soluble. 1
Mechanism of Action
Sodium dithionite functions as a reducing agent in the sickle solubility assay, which is a key diagnostic test used to detect the presence of HbS. The test works through the following mechanism:
- Sodium dithionite reduces hemoglobin molecules by removing oxygen
- When HbS is deoxygenated, it polymerizes and becomes insoluble
- Normal hemoglobin (HbA) remains soluble even when deoxygenated
- The insoluble HbS creates turbidity in the test solution, indicating a positive result
This chemical property allows laboratories to quickly identify the presence of HbS in patient samples as part of hemoglobinopathy screening protocols 1.
Clinical Application
The sickle solubility test is commonly used in hospital laboratories as part of screening algorithms for sickle cell disease:
- It serves as a rapid initial test to detect the presence of HbS
- A positive result indicates the presence of HbS but cannot differentiate between:
- Homozygous sickle cell disease (HbSS)
- Heterozygous sickle cell trait (HbAS)
- Compound heterozygous states (e.g., HbSC, HbS-beta thalassemia)
Therefore, a positive sickle solubility test typically triggers further testing with more definitive methods such as:
- High-performance liquid chromatography
- Capillary electrophoresis
- Mass spectrometry
- Gel electrophoresis 1
Important Limitations
The sickle solubility test has several important limitations that clinicians should be aware of:
- It cannot differentiate between sickle cell disease and sickle cell trait
- False negative results can occur in:
- Neonates (due to high levels of fetal hemoglobin)
- Heavily transfused patients (due to dilution with donor HbA)
- Should not be used in isolation for diagnosis 1
Chemical Properties
At the molecular level, sodium dithionite (Na₂S₂O₄) binds to deoxygenated hemoglobin at specific sites:
- The binding occurs at the interface between hemoglobin molecules
- Key residues involved include His116 and His117 of the beta subunit and Lys16 of the alpha subunit 2
This specific interaction with hemoglobin facilitates the reduction process that is essential for the sickle solubility test to function properly.